Magnetar Financial’s GSK GSK Stock Holding History

Magnetar Financial’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-500,000	Closed	-$490K	–	683
2024 Q3	$490K	Buy	+500,000	New	+$20.5M	0.01%	344
2023 Q2	–	Sell	-234,300	Closed	-$356K	–	545
2023 Q1	$356K	Sell	234,300 -2,240,500	-91%	-$78.4M	0.01%	494
2022 Q4	$1.19M	Buy	+2,474,800	New	+$82.4M	0.02%	496
2015 Q3	–	Sell	-800,000	Closed	-$41.6M	–	446
2015 Q2	$41.6M	Buy	+800,000	New	+$45M	0.59%	42

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Magnetar Financial's GSK Position: Q4 2024 in Review

Magnetar Financial sold out of GSK (GSK) in Q4 2024, closing a stake of 97,788 shares — an estimated $4M sold.

Magnetar Financial first reported a position in GSK in Q1 2022 and held it in 10 quarters. The position peaked at $70.8M in Q1 2024. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

Magnetar Financial reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
Magnetar Financial sold 97,788 GSK shares in Q4 2024, an estimated $4M.
Magnetar Financial first reported a position in GSK in Q1 2022 and held it in 10 quarters.
Magnetar Financial's GSK position peaked at $70.8M in Q1 2024.
848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Magnetar Financial's 13F filing for Q4 2024, filed 11 Feb 2025.